MNRT501
|
OriGene Technologies
|
TissueScan, Mouse Normal cDNA Array
|
|
|
|
HORT101
|
OriGene Technologies
|
TissueScan, Ovarian Cancer cDNA Array I
|
|
|
|
HORT301
|
OriGene Technologies
|
TissueScan, Ovarian Cancer cDNA Array I
|
|
|
|
HORT501
|
OriGene Technologies
|
TissueScan, Ovarian Cancer cDNA Array I
|
|
|
|
HORT102
|
OriGene Technologies
|
TissueScan, Ovarian Cancer cDNA Array II
|
|
|
|
HORT302
|
OriGene Technologies
|
TissueScan, Ovarian Cancer cDNA Array II
|
|
|
|
HORT502
|
OriGene Technologies
|
TissueScan, Ovarian Cancer cDNA Array II
|
|
|
|
HORT103
|
OriGene Technologies
|
TissueScan, Ovarian Cancer cDNA Array III
|
|
|
|
HORT303
|
OriGene Technologies
|
TissueScan, Ovarian Cancer cDNA Array III
|
|
|
|
HORT503
|
OriGene Technologies
|
TissueScan, Ovarian Cancer cDNA Array III
|
|
|
|
HORT104
|
OriGene Technologies
|
TissueScan, Ovarian Cancer cDNA Array IV
|
|
|
|
HORT304
|
OriGene Technologies
|
TissueScan, Ovarian Cancer cDNA Array IV
|
|
|
|
HORT504
|
OriGene Technologies
|
TissueScan, Ovarian Cancer cDNA Array IV
|
|
|
|
PNRT101
|
OriGene Technologies
|
TissueScan, Pancreatic Cancer cDNA Array I
|
|
|
|
PNRT301
|
OriGene Technologies
|
TissueScan, Pancreatic Cancer cDNA Array I
|
|
|
|
PNRT501
|
OriGene Technologies
|
TissueScan, Pancreatic Cancer cDNA Array I
|
|
|
|
HPRT101
|
OriGene Technologies
|
TissueScan, Prostate Cancer cDNA Array I
|
|
|
|
HPRT301
|
OriGene Technologies
|
TissueScan, Prostate Cancer cDNA Array I
|
|
|
|
HPRT501
|
OriGene Technologies
|
TissueScan, Prostate Cancer cDNA Array I
|
|
|
|
HPRT102
|
OriGene Technologies
|
TissueScan, Prostate Cancer cDNA Array II
|
|
|
|
HPRT302
|
OriGene Technologies
|
TissueScan, Prostate Cancer cDNA Array II
|
|
|
|
HPRT502
|
OriGene Technologies
|
TissueScan, Prostate Cancer cDNA Array II
|
|
|
|
HPRT103
|
OriGene Technologies
|
TissueScan, Prostate Cancer cDNA Array III
|
|
|
|
HPRT303
|
OriGene Technologies
|
TissueScan, Prostate Cancer cDNA Array III
|
|
|
|
HPRT503
|
OriGene Technologies
|
TissueScan, Prostate Cancer cDNA Array III
|
|
|
|